287 related articles for article (PubMed ID: 32135144)
1. Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro.
Sherratt SCR; Juliano RA; Mason RP
Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183254. PubMed ID: 32135144
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction.
Sherratt SCR; Mason RP
Chem Phys Lipids; 2018 May; 212():73-79. PubMed ID: 29355517
[TBL] [Abstract][Full Text] [Related]
3. Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid.
Sherratt SCR; Mason RP
Biochem Biophys Res Commun; 2018 Feb; 496(2):335-338. PubMed ID: 29331380
[TBL] [Abstract][Full Text] [Related]
4. Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes.
Mason RP; Jacob RF; Shrivastava S; Sherratt SCR; Chattopadhyay A
Biochim Biophys Acta; 2016 Dec; 1858(12):3131-3140. PubMed ID: 27718370
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
6. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers.
Egert S; Somoza V; Kannenberg F; Fobker M; Krome K; Erbersdobler HF; Wahrburg U
Eur J Clin Nutr; 2007 Mar; 61(3):314-25. PubMed ID: 16969378
[TBL] [Abstract][Full Text] [Related]
7. EPA and DHA containing phospholipids have contrasting effects on membrane structure.
Sherratt SCR; Juliano RA; Copland C; Bhatt DL; Libby P; Mason RP
J Lipid Res; 2021; 62():100106. PubMed ID: 34400132
[TBL] [Abstract][Full Text] [Related]
8. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism.
Mason RP; Jacob RF
Biochim Biophys Acta; 2015 Feb; 1848(2):502-9. PubMed ID: 25449996
[TBL] [Abstract][Full Text] [Related]
10. All n-3 PUFA are not the same: MD simulations reveal differences in membrane organization for EPA, DHA and DPA.
Leng X; Kinnun JJ; Cavazos AT; Canner SW; Shaikh SR; Feller SE; Wassall SR
Biochim Biophys Acta Biomembr; 2018 May; 1860(5):1125-1134. PubMed ID: 29305832
[TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats.
Willumsen N; Vaagenes H; Lie O; Rustan AC; Berge RK
Lipids; 1996 Jun; 31(6):579-92. PubMed ID: 8784738
[TBL] [Abstract][Full Text] [Related]
12. Formation of cyclic deoxyguanosine adducts from omega-3 and omega-6 polyunsaturated fatty acids under oxidative conditions.
Pan J; Chung FL
Chem Res Toxicol; 2002 Mar; 15(3):367-72. PubMed ID: 11896684
[TBL] [Abstract][Full Text] [Related]
13. New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease.
Preston Mason R
Curr Atheroscler Rep; 2019 Jan; 21(1):2. PubMed ID: 30637567
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK;
Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671
[TBL] [Abstract][Full Text] [Related]
15. Relationships of Fatty Acids, Delta-5 Desaturase Activity, and Lipid Profiles in Men with Acute Coronary Syndrome.
Arai K; Koba S; Yokota Y; Tsunoda F; Tsujita H; Kondo S; Tsukamoto S; Shoji M; Shinke T
J Atheroscler Thromb; 2020 Nov; 27(11):1216-1229. PubMed ID: 32595194
[TBL] [Abstract][Full Text] [Related]
16. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
Weintraub H
Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid.
John Chapman M; Preston Mason R
Pharmacol Ther; 2022 Dec; 240():108237. PubMed ID: 35772589
[TBL] [Abstract][Full Text] [Related]
18. Influence of long-chain polyunsaturated fatty acids on oxidation of low density lipoprotein.
Wander RC; Du SH; Thomas DR
Prostaglandins Leukot Essent Fatty Acids; 1998 Aug; 59(2):143-51. PubMed ID: 9774178
[TBL] [Abstract][Full Text] [Related]
19. A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study.
Maki KC; Bays HE; Ballantyne CM; Underberg JA; Kastelein JJP; Johnson JB; Ferguson JJ
J Am Heart Assoc; 2022 Mar; 11(6):e024176. PubMed ID: 35232215
[TBL] [Abstract][Full Text] [Related]
20. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
